William C Denby - Net Worth and Insider Trading
William C Denby Net Worth
The estimated net worth of William C Denby is at least $0 dollars as of 2024-09-24. William C Denby is the Director of DMK Pharmaceuticals Corp and owns about 1,554 shares of DMK Pharmaceuticals Corp (DMKPQ) stock worth over $0. Details can be seen in William C Denby's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William C Denby has not made any transactions after 2019-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William C Denby
William C Denby Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William C Denby owns 1 companies in total, including DMK Pharmaceuticals Corp (DMKPQ) .
Click here to see the complete history of William C Denby’s form 4 insider trades.
Insider Ownership Summary of William C Denby
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DMKPQ | DMK Pharmaceuticals Corp | 2019-05-24 | director |
William C Denby Latest Holdings Summary
William C Denby currently owns a total of 1 stock. William C Denby owns 1,554 shares of DMK Pharmaceuticals Corp (DMKPQ) as of May 24, 2019, with a value of $0.
Latest Holdings of William C Denby
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DMKPQ | DMK Pharmaceuticals Corp | 2019-05-24 | 1,554 | 0.00 | 0 |
Holding Weightings of William C Denby
William C Denby Form 4 Trading Tracker
According to the SEC Form 4 filings, William C Denby has made a total of 0 transactions in DMK Pharmaceuticals Corp (DMKPQ) over the past 5 years. The most-recent trade in DMK Pharmaceuticals Corp is the acquisition of 89 shares on May 24, 2019, which cost William C Denby around $10,000.
Insider Trading History of William C Denby
- 1
William C Denby Trading Performance
GuruFocus tracks the stock performance after each of William C Denby's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William C Denby is -35.8%. GuruFocus also compares William C Denby's trading performance to market benchmark return within the same time period. The performance of stocks bought by William C Denby within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William C Denby's insider trading performs compared to the benchmark.
Performance of William C Denby
William C Denby Ownership Network
William C Denby Owned Company Details
What does DMK Pharmaceuticals Corp do?
Who are the key executives at DMK Pharmaceuticals Corp?
William C Denby is the director of DMK Pharmaceuticals Corp. Other key executives at DMK Pharmaceuticals Corp include General Counsel Dorbin John W. Jr. , CFO Seth Cohen , and director & CEO Ebrahim Versi .
DMK Pharmaceuticals Corp (DMKPQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DMK Pharmaceuticals Corp (DMKPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DMK Pharmaceuticals Corp (DMKPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DMK Pharmaceuticals Corp (DMKPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
DMK Pharmaceuticals Corp Insider Transactions
William C Denby Mailing Address
Above is the net worth, insider trading, and ownership report for William C Denby. Currently GuruFocus does not have mailing address information for William C Denby.